Biopoin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biopoin, covering 2023-09-27 to 2023-09-27. Get the full timeline:
Most recent: EMA Authorised: Biopoin (epoetin theta) — Teva GmbH
1 regulatory and trial event tracked for Biopoin, covering 2023-09-27 to 2023-09-27. Get the full timeline:
Most recent: EMA Authorised: Biopoin (epoetin theta) — Teva GmbH